Suppr超能文献

银屑病治疗后甲氨蝶呤诱发的丘疹性皮疹。

Methotrexate-induced papular eruption following treatment of psoriasis.

作者信息

Mebazaa Amel, Kenani Nesrine, Denguezli Mohamed, Ben Salem Chaker, Ziadi Sonia, Sriha Badreddine, Belajouza Colandane, Nouira Rafiaa

机构信息

Department of Dermatology, Farhat Hached Hospital, Sousse Tunisia.

出版信息

Ann Pharmacother. 2008 Jan;42(1):138-41. doi: 10.1345/aph.1K271. Epub 2007 Dec 19.

Abstract

OBJECTIVE

To report a case of a diffuse papular eruption following treatment of psoriasis with methotrexate injections.

CASE REPORT

A 52-year-old woman presented with an extensive flare of psoriasis associated with joint pain, especially in her knees and elbows. She was treated with intramuscular injections of methotrexate 20 mg/wk. Ten hours after the second methotrexate injection, the patient experienced a diffuse pruritic papular eruption located mainly on the limbs. Histology showed foci of dyskeratosis in the mucosal layer and a polymorphic perivascular inflammatory infiltrate of the papillary dermis, suggesting a drug-induced skin reaction. According to the Naranjo probability scale, the papular eruption was probably caused by methotrexate. The drug was discontinued and papular lesions gradually disappeared.

DISCUSSION

Methotrexate-induced papular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases. Methotrexate-induced papular eruption following treatment of psoriasis has not been previously reported.

CONCLUSIONS

The pathogenesis of methotrexate-induced papular eruption in collagen vascular diseases may suggest cutaneous small-vessel vasculitis. In our patient, histology showed aspects of drug-induced skin reaction without vasculitis. Pathogenesis of methotrexate-induced papular eruption in psoriasis may involve immune mechanisms other than those of methotrexate-induced cutaneous vasculitis in collagen vascular disease.

摘要

目的

报告1例用甲氨蝶呤注射治疗银屑病后出现弥漫性丘疹性皮疹的病例。

病例报告

一名52岁女性,银屑病广泛发作并伴有关节疼痛,尤其是膝盖和肘部。她接受了每周20毫克甲氨蝶呤的肌肉注射治疗。第二次甲氨蝶呤注射后10小时,患者出现主要位于四肢的弥漫性瘙痒性丘疹性皮疹。组织学检查显示黏膜层有角化不良灶,乳头真皮层有多形性血管周围炎性浸润,提示药物性皮肤反应。根据Naranjo概率量表,丘疹性皮疹可能由甲氨蝶呤引起。停用该药物后,丘疹性皮损逐渐消失。

讨论

在胶原血管疾病急性加重的患者中,甲氨蝶呤治疗开始后不久很少报告甲氨蝶呤诱发的丘疹性皮疹。此前尚未有甲氨蝶呤治疗银屑病后诱发丘疹性皮疹的报告。

结论

胶原血管疾病中甲氨蝶呤诱发丘疹性皮疹的发病机制可能提示皮肤小血管血管炎。在我们的患者中,组织学检查显示为药物性皮肤反应,无血管炎表现。银屑病中甲氨蝶呤诱发丘疹性皮疹的发病机制可能涉及胶原血管疾病中甲氨蝶呤诱发皮肤血管炎以外的免疫机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验